Bone marrow transplantation for acute nonlymphocytic leukemia in first remission: analysis of prognostic factors
Bruce Bostrom(Minnesota West Community & Technical College), Anne I. Goldman(Meir Medical Center), William Krivit(Kennedy Krieger Institute), T Kim(University of Minnesota Medical Center), WG Woods(University of Minnesota Medical Center), RD Brunning(University of Minnesota), Philip B. McGlave(University of Minnesota), Norma K.C. Ramsay(University of Minnesota), David D. Hurd(Duke University), M Jr Nesbit(University of Minnesota Medical Center)
Cited by 61
Related Papers
Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma
|New England Journal of Medicine|2012|1.2k
Virus-associated hemophagocytic syndromeA benign histiocytic proliferation distinct from malignant histiocytosis
|Cancer|1979|1.1k
Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor Program
|New England Journal of Medicine|1993|848
Chemotherapy Compared with Autologous or Allogeneic Bone Marrow Transplantation in the Management of Acute Myeloid Leukemia in First Remission
|New England Journal of Medicine|1998|610